Microencapsulation of human spermatozoa increases membrane stability and DNA longevity.

Area of Science:

• Reproductive Medicine
• Biotechnology
• Sperm Preservation

Background:

• Microencapsulation of spermatozoa shows promise for in vitro sperm survival and has produced offspring in animals.
• Application in human reproductive medicine remains limited.
• Alginic acid microencapsulation is explored for human sperm preservation.

Purpose of the Study:

• To investigate the effect of alginic acid microencapsulation on human sperm viability and DNA fragmentation.
• To assess sperm quality after 24-hour storage at 37°C in microencapsulated and control groups.
• To explore potential applications in reproductive medicine.

Main Methods:

• Human spermatozoa were encapsulated in alginic acid.
• Sperm membrane integrity (viability) and sperm DNA fragmentation (SDF) were assessed after 24-hour storage at 37°C.
• Statistical analysis using Log-rank and Mantel-Cox tests was performed.

Main Results:

• Microencapsulation substantially improved cumulative sperm viability compared to controls (p < 0.001).
• Microencapsulation significantly reduced cumulative sperm DNA fragmentation (p < 0.001).
• Individual differences in dynamic behavior were significant for viability in microencapsulated samples (p = 0.021).

Conclusions:

• Alginic acid microencapsulation enhances human sperm viability and reduces DNA fragmentation during storage.
• The technique shows significant potential for improving outcomes in human reproductive medicine.
• Further research could establish microencapsulated human spermatozoa for clinical applications.